Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 19, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

MicroRNAs: tools for cancer diagnostics.

T Paranjape1, F J Slack, J B Weidhaas

  • 1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, 06520, USA.

Gut
|October 17, 2009
PubMed
Summary

MicroRNAs (miRNAs) are gene regulators crucial in cancer. Their distinct expression profiles in cancer cells offer significant potential for early cancer diagnosis and personalized treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the association of rs2910164 with cancer predisposition in an Irish cohort.

Endocrine connections·2017
Same author

cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation.

Oncogene·2016
Same author

Junk DNA and the long non-coding RNA twist in cancer genetics.

Oncogene·2015
Same author

A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer.

Oncogene·2014
Same author

A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.

Oncogene·2014

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are emerging as critical global gene regulators in both plants and animals.
  • MiRNAs function by reducing target gene protein levels with minimal impact on messenger RNA (mRNA).
  • Evidence increasingly highlights the significant role of miRNAs in the development and progression of various cancers.

Purpose of the Study:

  • To explore the diagnostic and therapeutic potential of microRNAs (miRNAs) in oncology.
  • To address the inadequacy in early cancer diagnosis and screening methods.
  • To investigate unique miRNA expression profiles for identifying early-stage cancers or precursor lesions.

Main Methods:

  • Analysis of miRNA expression data across different cancer types.
  • Comparison of miRNA profiles between cancerous and normal cells.
  • Review of existing literature on miRNA functions in cancer biology.

Main Results:

  • Cancer cells exhibit distinct miRNA expression profiles compared to normal cells.
  • Overexpressed miRNAs can act as oncogenes, while downregulated tumor suppressor miRNAs are observed in cancer.
  • MiRNA dysregulation is a hallmark of cancer, indicating its involvement in disease pathology.

Conclusions:

  • MicroRNAs (miRNAs) hold immense potential as biomarkers for early cancer detection and screening.
  • Unique miRNA signatures in cancer patients can facilitate personalized treatment approaches.
  • Further research into miRNAs is vital for advancing cancer diagnostics and patient care.

More Related Videos

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

Related Experiment Videos

Last Updated: Jun 19, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017